Cargando…
Phosphatidylcholine Metabolic Transformation and Progression Signature as a Pharmacodynamic Biomarker
Autor principal: | Aboagye, Eric O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157722/ https://www.ncbi.nlm.nih.gov/pubmed/21301046 |
Ejemplares similares
-
Lysophosphatidylcholines and phosphatidylcholines as biomarkers for stroke recovery
por: Huang, Meiling, et al.
Publicado: (2022) -
Rapid diagnosis of sepsis using biomarker signatures
por: Silman, Nigel James
Publicado: (2013) -
Inverse Phosphatidylcholine/Phosphatidylinositol Levels as Peripheral Biomarkers and Phosphatidylcholine/Lysophosphatidylethanolamine-Phosphatidylserine as Hippocampal Indicator of Postischemic Cognitive Impairment in Rats
por: Sabogal-Guáqueta, Angelica Maria, et al.
Publicado: (2018) -
Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker
por: Rae, Julie, et al.
Publicado: (2021) -
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
por: Wang, Zeneng, et al.
Publicado: (2011)